HIGHLIGHTS
- who: September and colleagues from the Sapienza University of Rome, Italy have published the Article: Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme, in the Journal: (JOURNAL)
- what: In this publication, the authors focused only on the high-penetrance susceptibility genes BRCA1 and BRCA2. In the context of this research, it is reasonable to test for HBOC genes in all breast and ovarian cancer patients, irrespective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.